ABG-WTT Global Life Science Capital Partners GP Ltd — Q4 2023 13F-HR

← ABG-WTT Global Life Science Capital Partners GP Ltd

Q4 2023 · 13F-HR

ABG-WTT Global Life Science Capital Partners GP Ltdholdings as filed

Filed 2024-02-14 · accession 0000950123-24-002155

$51.3M

Reported value

Positions

2023-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
75525N107	—	RAYZEBIO INC	$48.4M	94.4%	778,922	Common	SOLE
58406B202	MDVLQ	MEDAVAIL HOLDINGS	$1.3M	2.63%	300,588	Common	SOLE
75340L104	RPID	RAPID MICRO BIOSYSTEMS INC	$768,339	1.50%	1,038,296	Common	SOLE
745848101	LUNG	PULMONX CORP	$767,601	1.50%	60,204	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.